Instrumented functional reach test differentiates individuals at high risk for Parkinson’s disease from controls

The functional reach test (FR) as a complex measure of balance including limits of stability has been proven to differentiate between patients with Parkinson’s disease (PD) and controls. Recently it has been shown that the instrumentation of the FR (iFR) with a wearable sensor may increase this diag...

Full description

Bibliographic Details
Main Authors: Sandra Elisabeth Hasmann, Daniela eBerg, Markus Alexander Hobert, David eWeiss, Ulrich eLindemann, Johannes eStreffer, Inga eLiepelt-Scarfone, Walter eMaetzler
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-10-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00286/full
id doaj-d7548b6dadb6415b913337f22a2bfba5
record_format Article
spelling doaj-d7548b6dadb6415b913337f22a2bfba52020-11-24T22:37:42ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652014-10-01610.3389/fnagi.2014.0028688780Instrumented functional reach test differentiates individuals at high risk for Parkinson’s disease from controlsSandra Elisabeth Hasmann0Daniela eBerg1Markus Alexander Hobert2David eWeiss3Ulrich eLindemann4Johannes eStreffer5Inga eLiepelt-Scarfone6Walter eMaetzler7Center of Neurology, University hospital of Tuebingen, GermanyCenter of Neurology, University hospital of Tuebingen, GermanyCenter of Neurology, University hospital of Tuebingen, GermanyCenter of Neurology, University hospital of Tuebingen, GermanyRobert-Bosch-KrankenhausJohnson & JohnsonCenter of Neurology, University hospital of Tuebingen, GermanyCenter of Neurology, University hospital of Tuebingen, GermanyThe functional reach test (FR) as a complex measure of balance including limits of stability has been proven to differentiate between patients with Parkinson’s disease (PD) and controls. Recently it has been shown that the instrumentation of the FR (iFR) with a wearable sensor may increase this diagnostic accuracy. This cross-sectional study aimed at investigating whether the iFR has the potential to differentiate individuals with high risk for PD (HRPD) from controls, as the delineation of such individuals would allow for e.g. early neuromodulation. Thirteen PD patients, 13 controls and 31 HRPD were investigated. HRPD was defined by presence of an enlarged area of hyperechogenicity in the mesencephalon on transcranial sonography and either one motor sign or two risk and prodromal markers of PD. All participants were asked to reach with their right arm forward as far as possible and hold this position for 10 seconds. During this period, sway parameters were assessed with an accelerometer worn at the lower back. Extracted parameters which differed significantly between PD patients and controls in our cohort [FR distance (shorter in PD), anterior-posterior (AP) and mediolateral (ML) acceleration (both lower in PD)] as well as JERK which has been shown to differentiate HRPD from controls and PD in a previous study, were included in a model which was then used to differentiate HRPD from controls. The model yielded an area under the curve of 0.77, with a specificity of 85%, and a sensitivity of 74%. These results suggest that the iFR can contribute to an assessment panel focusing on the definition of HRPD individuals.http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00286/fullbalanceneurodegenerationswaylimit of stabilityprodromal Parkinson’s disease
collection DOAJ
language English
format Article
sources DOAJ
author Sandra Elisabeth Hasmann
Daniela eBerg
Markus Alexander Hobert
David eWeiss
Ulrich eLindemann
Johannes eStreffer
Inga eLiepelt-Scarfone
Walter eMaetzler
spellingShingle Sandra Elisabeth Hasmann
Daniela eBerg
Markus Alexander Hobert
David eWeiss
Ulrich eLindemann
Johannes eStreffer
Inga eLiepelt-Scarfone
Walter eMaetzler
Instrumented functional reach test differentiates individuals at high risk for Parkinson’s disease from controls
Frontiers in Aging Neuroscience
balance
neurodegeneration
sway
limit of stability
prodromal Parkinson’s disease
author_facet Sandra Elisabeth Hasmann
Daniela eBerg
Markus Alexander Hobert
David eWeiss
Ulrich eLindemann
Johannes eStreffer
Inga eLiepelt-Scarfone
Walter eMaetzler
author_sort Sandra Elisabeth Hasmann
title Instrumented functional reach test differentiates individuals at high risk for Parkinson’s disease from controls
title_short Instrumented functional reach test differentiates individuals at high risk for Parkinson’s disease from controls
title_full Instrumented functional reach test differentiates individuals at high risk for Parkinson’s disease from controls
title_fullStr Instrumented functional reach test differentiates individuals at high risk for Parkinson’s disease from controls
title_full_unstemmed Instrumented functional reach test differentiates individuals at high risk for Parkinson’s disease from controls
title_sort instrumented functional reach test differentiates individuals at high risk for parkinson’s disease from controls
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2014-10-01
description The functional reach test (FR) as a complex measure of balance including limits of stability has been proven to differentiate between patients with Parkinson’s disease (PD) and controls. Recently it has been shown that the instrumentation of the FR (iFR) with a wearable sensor may increase this diagnostic accuracy. This cross-sectional study aimed at investigating whether the iFR has the potential to differentiate individuals with high risk for PD (HRPD) from controls, as the delineation of such individuals would allow for e.g. early neuromodulation. Thirteen PD patients, 13 controls and 31 HRPD were investigated. HRPD was defined by presence of an enlarged area of hyperechogenicity in the mesencephalon on transcranial sonography and either one motor sign or two risk and prodromal markers of PD. All participants were asked to reach with their right arm forward as far as possible and hold this position for 10 seconds. During this period, sway parameters were assessed with an accelerometer worn at the lower back. Extracted parameters which differed significantly between PD patients and controls in our cohort [FR distance (shorter in PD), anterior-posterior (AP) and mediolateral (ML) acceleration (both lower in PD)] as well as JERK which has been shown to differentiate HRPD from controls and PD in a previous study, were included in a model which was then used to differentiate HRPD from controls. The model yielded an area under the curve of 0.77, with a specificity of 85%, and a sensitivity of 74%. These results suggest that the iFR can contribute to an assessment panel focusing on the definition of HRPD individuals.
topic balance
neurodegeneration
sway
limit of stability
prodromal Parkinson’s disease
url http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00286/full
work_keys_str_mv AT sandraelisabethhasmann instrumentedfunctionalreachtestdifferentiatesindividualsathighriskforparkinsonsdiseasefromcontrols
AT danielaeberg instrumentedfunctionalreachtestdifferentiatesindividualsathighriskforparkinsonsdiseasefromcontrols
AT markusalexanderhobert instrumentedfunctionalreachtestdifferentiatesindividualsathighriskforparkinsonsdiseasefromcontrols
AT davideweiss instrumentedfunctionalreachtestdifferentiatesindividualsathighriskforparkinsonsdiseasefromcontrols
AT ulrichelindemann instrumentedfunctionalreachtestdifferentiatesindividualsathighriskforparkinsonsdiseasefromcontrols
AT johannesestreffer instrumentedfunctionalreachtestdifferentiatesindividualsathighriskforparkinsonsdiseasefromcontrols
AT ingaeliepeltscarfone instrumentedfunctionalreachtestdifferentiatesindividualsathighriskforparkinsonsdiseasefromcontrols
AT walteremaetzler instrumentedfunctionalreachtestdifferentiatesindividualsathighriskforparkinsonsdiseasefromcontrols
_version_ 1725715827395657728